Lecture 35+36 Flashcards
Hurler syndrome
deficiency in Iduronidase
accumulation of dermatan sulfate and heparan sulfate
urine will be + for glycosaminoglycans
enzyme replacement therapy can be done
symptoms/signs: coarser facial features short developmental delay hepatomegaly and splenomegaly reduced joint motility corneal clouding
Hunter syndrome
milder form of hurler syndrome
X linked recessive (mainly males)
deficient in iduronate sulfatase
symptoms: coarser facial features hepatosplenomegaly mild developmental delay NO corneal clouding
enzyme replacement therapy
Tay-sachs disease
deficiency in beta-hexosaminidase A
accumulation of GM2
seen to have: progressive neurodegeneration blindness (cherry red spot on macula) developmental delay usually fatal between 2-6 years
Gaucher disease
most common lysosomal storage disorder
deficient in Beta-glucosidase
accumulation of glucosyl ceramide or glucocerebroside
symptoms:
no neurological damage
hepatosplenomegaly
osteoporosis of long bones (bone crisis)
can use enzyme replacement therapy
Fabry disease
X-linked recessive disorder (mainly males are affected)
deficiency in alpha-galactosidase
accumulation of globoside (ceramide trihexoside)
symptoms:
peripheral neuropathy
accumulation of globoside in blood vessels, skin, kidney, nerves, heart
Niemann-Pick disease
deficiency in Sphingomyelinase
accumulation of sphingomyelin in neuronal tissues (foamy cell appearance)
Type A:
severe infantile form
fatal by 2-3 years
cherry-red spot on macula (blindness)
Type B:
appears later in childhood
will have hepatosplenomegaly
Metachromatic leukodystrophy
deficient in aryl sulfatase A
accumulation of sulfatide
progressive paralysis and demyelination
Pompe disease
Generalized accumulation of glycogen in heart, muscle, kidney and liver as vacuoles in the lysosomes
glycogen storage disorder (II)
I-Cell disease
defect in trafficking enzymes to the lysosomes
the golgi fails to add the mannose-6 marker, thus they do not go to the lysosome
will be secreted into the blood
will have inclusion cells
symptoms similar to Hurler syndrome, but more severe and earlier age of onset
Migalastat
drug treatment for Fabry- pharmaceutical
chaperone which helps the mutated protein fold correctly and recover some activity
Miglustat
drug treatment for Gaucher type 1, inhibits the
formation of glycosphingolipids and this is called “substrate reduction”
role of copper in metabolism
used in lysyl oxidase (collagen)
tyrosinase (melanin synthesis)
cytochromes (ETC)
superoxide dismutase (ROS)
forms ceruloplasmin in the liver
copper transport protien
helps in iron metabolism
The life of copper
copper is transported to the liver via albumin
forms ceruloplasmin in the liver and then secreted into plasma (requires copper transporting ATPase)
aged ceruloplasmin is taken up by liver and secreted into the bile (copper transporting ATPase)
role of ceruloplasmin and iron metabolism
ceruloplasmin (ferroxidase) converts ferrous iron to the ferric form
incorporates the ferric ion into transferrin
mobilizes ferric ions from ferritin and hemosiderin
acute phase protein
copper deficiency
microcytic anemia (smaller RBCs) less iron mobilization
degradation of vascular tissue (decreased lysyl oxidase activity)
increased risk of bleeding
defects in pigmentation of hair